Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 8, 2009, Pages 3520-3523

  Kotsakis, Stathis D ^a   Papagiannitsis, Costas C ^a   Tzelepi, Eva ^a   Tzouvelekis, Leonidas S ^b   Miriagou, Vivi ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CEPHALOSPORIN; CEPHALOSPORINASE; CYSTEINYLMETHIONYLTYROSINE 30; GLYCINE; UNCLASSIFIED DRUG; VALINE;

ARTICLE; CITROBACTER FREUNDII; CONTROLLED STUDY; ENZYME SPECIFICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

AZTREONAM; BETA-LACTAMASES; BETA-LACTAMS; CEFTAZIDIME; CEPHALOSPORINS; ESCHERICHIA COLI PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY;

EID: 67749120059     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00219-09     Document Type: Article

References (27)

1. Barlow, M., and B. G. Hall. 2003. Experimental prediction of the evolution of cefepime resistance from the CMY-2 AmpC β-lactamase. Genetics 164: 23-29.
2. Bauvois, C., A. Shimizu Ibuka, A. Celso, J. Alba, Y. Ishii, J.-M. Frère, and M. Galleni. 2005. Kinetic properties of four plasmid-mediated AmpC β-lactamases. Antimicrob. Agents Chemother. 49:4240-4246.
3. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
4. Crichlow, G. V., A. P. Kuzin, M. Nukaga, K. Mayama, T. Sawai, and J. R. Knox. 1999. Structure of the extended-spectrum class C β-lactamase of Enterobacter cloacae GC1, a natural mutant with a tandem tripeptide insertion. Biochemistry 38:10256-10261.
5. Eswar, N., B. Webb, M. A. Marti-Renom, M. S. Madhusudhan, D. Eramian, M. Y. Shen, U. Pieper, and A. Sali. 2007. Comparative protein structure modeling using MODELLER, p. 2.9.1-2.9.31. In J. E. Coligan, B. M. Dunn, D. W. Speicher, P. T. Wingfield, and H. L. Ploegh (ed.), Current protocols in protein science. John Wiley & Sons, Inc., New York, NY.
6. Galleni, M., G. Amicosante, and J.-M. Frère. 1988. A survey of the kinetic parameters of class C β-lactamases. Cephalosporins and other β-lactam compounds. Biochem. J. 255:123-129.
7. Hidri, N., G. Barnaud, D. Decre, C. Cerceau, V. Lalande, J. C. Petit, R. Labia, and G. Arlet. 2005. Resistance to ceftazidime is associated with a S220Y substitution in the omega loop of the AmpC β-lactamase of a Serratia marcescens clinical isolate. J. Antimicrob. Chemother. 55:496-499.
8. Honoré, N., M. H. Nicolas, and S. T. Cole. 1989. Regulation of enterobacterial cephalosporinase production: the role of a membrane-bound sensory transducer. Mol. Microbiol. 3:1121-1130.
9. Jacoby, G. A. 2009. AmpC β-lactamases. Clin. Microbiol. Rev. 22:161-182.
10. Laskowski, R. A., M. W. MacArthur, D. S. Moss, and J. M. Thornton. 1993. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26:283-291.
11. Mammeri, H., and P. Nordmann. 2007. Extended-spectrum cephalosporinases in Enterobacteriaceae. Anti-Infect. Agents Med. Chem. 6:71-82.
12. Matsumura, N., S. Minami, and S. Mitsuhashi. 1998. Sequences of homologous β-lactamases from clinical isolates of Serratia marcescens with different substrate specificities. Antimicrob. Agents Chemother. 42:176-179.
13. Nordmann, P., and H. Mammeri. 2007. Extended-spectrum cephalosporinases: structure, detection, and epidemiology. Future Microbiol. 2:297-307.
14. Nukaga, M., S. Haruta, K. Tanimoto, K. Kogure, K. Taniguchi, M. Tamaki, and T. Sawai. 1995. Molecular evolution of a class C β-lactamase extending its substrate specificity. J. Biol. Chem. 270:5729-5735.
15. Nukaga, M., S. Kumar, K. Nukaga, R. F. Pratt, and J. R. Knox. 2004. Hydrolysis of third-generation cephalosporins by class C beta-lactamases. Structures of a transition state analog of cefotaxime in wild-type and extended spectrum enzymes. J. Biol. Chem. 279:9344-9352.
16. Nukaga, M., K. Taniguchi, Y. Washio, and T. Sawai. 1998. Effect of an amino acid insertion into the omega loop region of a class C β-lactamase on its substrate specificity. Biochemistry 37:10461- 10468.
17. Papagiannitsis, C. C., L. S. Tzouvelekis, E. Tzelepi, and V. Miriagou. 2007. Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli. Antimicrob. Agents Chemother. 51:3763-3767.
18. Patera, A., L. C. Blaszczak, and B. K. Shoichet. 2000. Crystal structure of substrate and inhibitor complexes with AmpC β-lactamase: possible implications for substrate-assisted catalysis. J. Am. Chem. Soc. 122:10504-10512.
19. Philippon, A., G. Arlet, and G. A. Jacoby. 2002. Plasmid-determined AmpCtype beta-lactamases. Antimicrob. Agents Chemother. 46:1-11.
20. Pope, C. E., P. E. Carter, and H. Heffernan. 4 May 2009. CMY-29 and CMY-30: two novel plasmid-mediated AmpC β-lactamases. Antimicrob. Agents Chemother. doi:10.1128/AAC.01586-08.
21. Power, P., M. Galleni, J. A. Ayala, and G. Gutkind. 2006. Biochemical and molecular characterization of three new variants of AmpC β-lactamases from Morganella morganii. Antimicrob. Agents Chemother. 50:962-967.
22. Powers, R. A., E. Caselli, P. J. Focia, F. Prati, and B. K. Shoichet. 2001. Structures of ceftazidime and its transition-state analogue in complex with AmpC β-lactamase: implications for resistance mutations and inhibitor design. Biochemistry 40:9207-9214.
23. Tsukamoto, K., R. Ohno, M. Nukaga, and T. Sawai. 1992. The effect of amino acid substitution at position 219 of Citrobacter freundii cephalosporinase on extension of its substrate spectrum. Eur. J. Biochem. 207:1123-1127.
24. Vu, H., and H. Nikaido. 1985. Role of β-lactam hydrolysis in the mechanism of resistance of a β-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum β-lactams. Antimicrob. Agents Chemother. 27:393-398.
25. CMY-bearing plasmids among clinical Escherichia coli and Klebsiella pneumoniae isolates and emergence of cefepime-hydrolyzing CMY-19. Antimicrob. Agents Chemother. 50:534-541.
26. Zhang, Z., Y. Yu, J. M. Musser, and T. Palzkill. 2001. Amino acid sequence determinants of extended-spectrum cephalosporin hydrolysis by the class C P99 β-lactamase. J. Biol. Chem. 276:46568-46574.
27. Zioga, A., J. M. Whichard, S. D. Kotsakis, L. S. Tzouvelekis, E. Tzelepi, and V. Miriagou. 2009. CMY-31 and CMY-36 cephalosporinases encoded by ColE1 plasmids. Antimicrob. Agents Chemother. 53:1256-1259.